Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000434913 | SCV000524248 | benign | not specified | 2016-09-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000434913 | SCV000711857 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Ile1875Val in exon 8 of ALMS1: This variant is not expected to have clinical s ignificance because it has been identified in 85.85% (1135/1322) of African chro mosomes by the 1000 Genomes Project (Phase 3; dbSNP rs6546838). |
Labcorp Genetics |
RCV000860244 | SCV001000226 | benign | Alstrom syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000860244 | SCV001769056 | benign | Alstrom syndrome | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002348190 | SCV002649262 | benign | Cardiovascular phenotype | 2018-12-21 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004710019 | SCV005242460 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000860244 | SCV001463051 | benign | Alstrom syndrome | 2020-09-16 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000434913 | SCV001742239 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000434913 | SCV001925048 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000434913 | SCV001959135 | benign | not specified | no assertion criteria provided | clinical testing |